Mary Tagliaferri - 31 Jan 2024 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)

Reporting relationship: Director
Issuer ticker: ENZB
Reported as of: 31 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Feb 2024, 21:01:32 UTC
Prior SEC filing: 14 Sep 2023
Next SEC filing: 27 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Mary Tagliaferri

Key filing fact

Mary Tagliaferri filed Form 4 for ENZO BIOCHEM INC (ENZB) on 02 Feb 2024.

Key facts

This page summarizes Mary Tagliaferri's Form 4 filing for ENZO BIOCHEM INC (ENZB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Feb 2024, 21:01.

Change

Previous filing in this sequence was filed on 14 Sep 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENZ transaction

Common Stock

Award

Transaction value: $0
Shares: +79,365
Change %: +34%
Price: $0.000000
Shares after: 312,383
Date: 31 Jan 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person was granted Restricted Stock Units that will fully vest upon the earlier of: (i) the first anniversary of the grant date (i.e., January 31, 2025), or (ii) a change of control event.